| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |